RxDoctor Payments DataLook up a doctor →

William Cook, MD

Urology · Tulsa, OKNPI 1578583423

Payments from drug & device makers

$8,158in general payments, 2019–2025

Across 343 payments — averaging $23.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teleflex LLC$1K
  • Johnson & Johnson$1K
  • Astellas Pharma US Inc$818
  • Coloplast$459
  • Novartis$422
  • Bayer$409
  • plus $4K from 39 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Teleflex LLC18$1,039
Johnson & Johnson(2 entities)55$1,023
Astellas Pharma US Inc30$818
Coloplast21$459
Novartis17$422
Bayer19$409
Pfizer18$403
Merck18$368
Urogen Pharma, Inc.10$296
Amgen13$284
Dendreon Pharmaceuticals LLC10$262
Tolmar Pharmaceuticals, Inc.12$228
Telix Pharmaceuticals4$224
Boston Scientific11$203
Sumitomo Pharma America, Inc.8$186
Palette Life Sciences, Inc.2$176
AbbVie(2 entities)8$153
Accord Healthcare, Inc.6$108
Endo Pharmaceuticals Inc.7$99
Ferring Pharmaceuticals Inc.4$91
Verity Pharmaceuticals Inc.4$86
Progenics Pharmaceuticals, Inc.3$81
Immunitybio, Inc.2$76
Sun Pharmaceutical Industries Inc.3$55
Antares Pharma, Inc.3$50
Neotract Inc.3$50
Conmed Corporation1$47
AstraZeneca2$38
Myovant Sciences Inc.2$37
Urovant Sciences Inc2$37
Endo USA, Inc.2$36
GSK3$34
Zyla Life Sciences, Inc.2$33
Blue Earth Diagnostics2$32
Procept Biorobotics Corporation1$30
Vertex1$30
Therapeuticsmd, Inc.2$29
Myriad Genetic Laboratories, Inc.1$25
Clovis Oncology, Inc.2$24
Foundation Medicine, Inc.1$23
Novo Nordisk1$21
Tolmar, Inc.1$20
Travere Therapeutics, Inc.1$15
Urogpo LLC2$0
SN Holdings, LLC5$0

How this compares

$8,158 in reported general payments places this provider in the 70th percentile of 145 urology providers in Oklahoma.

See all urology providers in Oklahoma →

Medicare billing

Part B allowed, 2024
$529,673
Medicare patients
914
Services billed
16,074

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other urology in Tulsa

See the full list for Oklahoma →

Where these figures come from

Is this you, or does something look wrong? →